CommercialCoverageMedium impact
Implantable Infusion Pump
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Pain Management, Neurology +3 more·Pharmacy
We identified it
Jun 20, 2026
Summary
This is a comprehensive policy defining medical necessity criteria for implantable infusion pumps across various conditions including cancer, chronic pain, spasticity, and diabetes. The policy establishes that pumps are medically necessary for specific FDA-approved indications but investigational for other uses.
Action Required
Immediately: Review current implantable infusion pump claims to ensure they meet the medical necessity criteria outlined in this policy. Billing team must verify that all pump placements are for covered indications (primary liver cancer, metastatic colorectal cancer to liver, ovarian cancer, severe chronic pain after successful trial, spasticity, or diabetes with inadequate glycemic control). Update prior authorization processes to require documentation of successful pain trials showing >50% reduction before approving pumps for chronic pain. Flag any pump requests for investigational uses (head/neck cancers, gastric cancer, osteomyelitis) as non-covered.